Bob Soh

Bob Soh has held a variety of roles in the medical and finance industries. From 2007 to 2011, they worked as a Department of Surgery (Neurosurgery) at Royal Melbourne Hospital, Royal North Shore Hospital, and Liverpool Hospital. From 2012 to 2015, they were an Examiner and Demonstrator at the University of Melbourne. Bob then worked as Acting Chief Executive Officer at Cardiora from 2015 to 2016. From 2016 to 2017, they were an Investment Associate, Investment Manager, and Senior Investment Manager at Brandon Capital. In 2017, they were a Board Observer at EBR Systems, Inc. From 2020 to 2022, they were a Director at Glyscend Incorporated, and they are currently an Alternate Director at Entact Bio.

Bob Soh obtained a Bachelor of Medicine and Bachelor of Surgery from the University of Melbourne in 2001-2006, followed by a Bachelors of Medical Science in 2001-2003. In 2011, they completed a Graduate Diploma in Surgical Anatomy at the University of Melbourne before graduating from the Australian Institute of Company Directors with a Graduate of the Australian Institute of Company Directors (GAICD) in 2016.